FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082996872> ?p ?o ?g. }

• W3082996872 endingPage "1943" @default.
• W3082996872 startingPage "1933" @default.
• W3082996872 abstract "ConspectusAsymmetric synthesis has posed a significant challenge to organic chemists for over a century. Several strategies have been developed to synthesize enantiomerically enriched compounds, which are ubiquitous in the pharmaceutical and agrochemical industries. While many organometallic and organic catalysts have been found to mediate thermal enantioselective reactions, the field of photochemistry lacks similar depth. Recently, chiral 1,3,2-oxazaborolidines have made the transition from Lewis acids that were exclusively applied to thermal reactions to catalysts for enantioselective photochemical reactions. Due to their modular structure, various 1,3,2-oxazaborolidines are readily available and can be easily fitted to a given chemical transformation. Their use holds great promise for future developments in photochemistry. This Account gives an overview of the substrate classes that are known to undergo enantioselective photochemical transformations in the presence of chiral 1,3,2-oxazaborolidines and touches on the catalytic mode of action, on the proposed enantiodifferentiation mechanism, as well as on recent computational studies.Based on the discovery that the presence of Lewis acids enhances the efficiency of coumarin [2 + 2] photocycloadditions, chiral 1,3,2-oxazaborolidines were applied in 2010 for the first time to prepare enantiomerically enriched photoproducts. These Lewis acids were then successfully used in intramolecular [2 + 2] photocycloaddition reactions of 1-alkenoyl-5,6-dihydro-4-pyridones and 3-alkenyloxy-2-cycloalkenones. In the course of this work, it became evident that the chiral 1,3,2-oxazaborolidine must be tailored to the specific reaction; it was shown that both inter- and intramolecular [2 + 2] photocycloadditions of cyclic enones can be conducted enantioselectively, but the aryl rings of the chiral Lewis acids require different substitution patterns. In all [2 + 2] photocycloaddition reactions in which chiral 1,3,2-oxazaborolidines were used as catalysts, the catalyst loading could not be decreased below 50 mol % without sacrificing enantioselectivity due to competitive racemic background reactions. To overcome this constraint, substrates that reacted exclusively when bound to an oxazaborolidine were tested, notably phenanthrene-9-carboxaldehydes and cyclohexa-2,4-dienones. The former substrate class underwent an ortho photocycloaddition, the latter an oxadi-π-methane rearrangement. Several new 1,3,2-oxazaborolidines were designed, and the products were obtained in high enantioselectivity with only 10 mol % of catalyst. Recently, an iridium-based triplet sensitizer was employed to facilitate enantioselective [2 + 2] photocycloadditions of cinnamates with 25 mol % of chiral 1,3,2-oxazaborolidine. In this case, the relatively low catalyst loading was possible because the oxazaborolidine–substrate complex exhibits a lower triplet energy and an improved electronic coupling compared to the uncomplexed substrate, allowing for a selective energy transfer.By synthetic and theoretical studies, it has become evident that chiral 1,3,2-oxazaborolidines are multifaceted catalysts: they change absorption behavior, alter energetic states, and induce chirality. While a diverse set of substrates has been shown to undergo enantioselective photochemical transformations in the presence of chiral 1,3,2-oxazaborolidines either through direct excitation or through triplet sensitization, these catalysts took on different roles for different substrates. Based on the studies presented in this Account, it can be assumed that there are still more photochemical reactions and substrate classes that could profit from chiral 1,3,2-oxazaborolidines." @default.
• W3082996872 created "2020-09-11" @default.
• W3082996872 creator A5025015822 @default.
• W3082996872 creator A5072082329 @default.
• W3082996872 date "2020-09-03" @default.
• W3082996872 modified "2023-10-03" @default.
• W3082996872 title "Chiral 1,3,2-Oxazaborolidine Catalysts for Enantioselective Photochemical Reactions" @default.
• W3082996872 cites W1923246623 @default.
• W3082996872 cites W1975532762 @default.
• W3082996872 cites W1981400260 @default.
• W3082996872 cites W1990586799 @default.
• W3082996872 cites W1992262102 @default.
• W3082996872 cites W1997817290 @default.
• W3082996872 cites W2004550171 @default.
• W3082996872 cites W2014899204 @default.
• W3082996872 cites W2026985246 @default.
• W3082996872 cites W2030877598 @default.
• W3082996872 cites W2036376341 @default.
• W3082996872 cites W2039753445 @default.
• W3082996872 cites W2054930916 @default.
• W3082996872 cites W2069617654 @default.
• W3082996872 cites W2069931068 @default.
• W3082996872 cites W2076015884 @default.
• W3082996872 cites W2081654714 @default.
• W3082996872 cites W2085120957 @default.
• W3082996872 cites W2086246877 @default.
• W3082996872 cites W2086291886 @default.
• W3082996872 cites W2092686580 @default.
• W3082996872 cites W2095058788 @default.
• W3082996872 cites W2101105671 @default.
• W3082996872 cites W2110976565 @default.
• W3082996872 cites W2113029761 @default.
• W3082996872 cites W2117651106 @default.
• W3082996872 cites W2134220433 @default.
• W3082996872 cites W2136162705 @default.
• W3082996872 cites W2149501066 @default.
• W3082996872 cites W2158178979 @default.
• W3082996872 cites W2165880526 @default.
• W3082996872 cites W2315130814 @default.
• W3082996872 cites W2317520189 @default.
• W3082996872 cites W2342772717 @default.
• W3082996872 cites W2474807251 @default.
• W3082996872 cites W2788634669 @default.
• W3082996872 cites W2794267212 @default.
• W3082996872 cites W2802201914 @default.
• W3082996872 cites W2845399883 @default.
• W3082996872 cites W2895283047 @default.
• W3082996872 cites W2899115703 @default.
• W3082996872 cites W2937068234 @default.
• W3082996872 cites W2947345772 @default.
• W3082996872 cites W2952681731 @default.
• W3082996872 cites W2960230002 @default.
• W3082996872 cites W2965549607 @default.
• W3082996872 cites W2994317792 @default.
• W3082996872 doi "https://doi.org/10.1021/acs.accounts.0c00379" @default.
• W3082996872 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7497702" @default.
• W3082996872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32880165" @default.
• W3082996872 hasPublicationYear "2020" @default.
• W3082996872 type Work @default.
• W3082996872 sameAs 3082996872 @default.
• W3082996872 citedByCount "42" @default.
• W3082996872 countsByYear W30829968722021 @default.
• W3082996872 countsByYear W30829968722022 @default.
• W3082996872 countsByYear W30829968722023 @default.
• W3082996872 crossrefType "journal-article" @default.
• W3082996872 hasAuthorship W3082996872A5025015822 @default.
• W3082996872 hasAuthorship W3082996872A5072082329 @default.
• W3082996872 hasBestOaLocation W30829968721 @default.
• W3082996872 hasConcept C146686406 @default.
• W3082996872 hasConcept C161790260 @default.
• W3082996872 hasConcept C163638829 @default.
• W3082996872 hasConcept C178790620 @default.
• W3082996872 hasConcept C185592680 @default.
• W3082996872 hasConcept C21951064 @default.
• W3082996872 hasConcept C75079739 @default.
• W3082996872 hasConceptScore W3082996872C146686406 @default.
• W3082996872 hasConceptScore W3082996872C161790260 @default.
• W3082996872 hasConceptScore W3082996872C163638829 @default.
• W3082996872 hasConceptScore W3082996872C178790620 @default.
• W3082996872 hasConceptScore W3082996872C185592680 @default.
• W3082996872 hasConceptScore W3082996872C21951064 @default.
• W3082996872 hasConceptScore W3082996872C75079739 @default.
• W3082996872 hasFunder F4320308269 @default.
• W3082996872 hasFunder F4320309608 @default.
• W3082996872 hasFunder F4320320879 @default.
• W3082996872 hasFunder F4320322572 @default.
• W3082996872 hasFunder F4320323383 @default.
• W3082996872 hasFunder F4320338335 @default.
• W3082996872 hasIssue "9" @default.
• W3082996872 hasLocation W30829968721 @default.
• W3082996872 hasLocation W30829968722 @default.
• W3082996872 hasOpenAccess W3082996872 @default.
• W3082996872 hasPrimaryLocation W30829968721 @default.
• W3082996872 hasRelatedWork W2069931068 @default.
• W3082996872 hasRelatedWork W2154956352 @default.
• W3082996872 hasRelatedWork W2949595504 @default.
• W3082996872 hasRelatedWork W2950721603 @default.
• W3082996872 hasRelatedWork W2951188401 @default.

• next